Activating Compound | Comment | Organism | Structure |
---|---|---|---|
Calmodulin | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [eukaryotic elongation factor 2] | Homo sapiens | eukaryotic elongation factor 2 is inactivated when it is phosphorylated on Thr56 by the enzyme | ADP + [eukaryotic elongation factor 2] phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O00418 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-375 cell | - |
Homo sapiens | - |
melanoma cell | - |
Homo sapiens | - |
SK-MEL-28 cell | - |
Homo sapiens | - |
SK-MEL-5 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [eukaryotic elongation factor 2] | eukaryotic elongation factor 2 is inactivated when it is phosphorylated on Thr56 by the enzyme | Homo sapiens | ADP + [eukaryotic elongation factor 2] phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
calmodulin-dependent protein kinase III | - |
Homo sapiens |
EEF-2K | - |
Homo sapiens |
eukaryotic elongation factor-2 kinase | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | doxorubicin treatment activates the enzyme in the melanoma cells | up |
General Information | Comment | Organism |
---|---|---|
malfunction | enzyme silencing blunts autophagic responses, but promotes doxorubicin-induced pyroptotic cell death in melanoma cells. Enzyme suppressionresults in inhibiting autophagy and augmenting pyroptosis, thus modulating the sensitivity of melanoma cells to doxorubicin | Homo sapiens |
physiological function | the enzyme plays a the regulatory role of in pyroptosis in doxorubicin-treated human melanoma cells. The enzyme dictates the cross-talk between pyroptosis and autophagy in doxorubicin-treated human melanoma cells | Homo sapiens |